• Study on B-Cell Levels in Infants Exposed to Ocrelizumab During Pregnancy for Mothers with Multiple Sclerosis or Clinically Isolated Syndrome

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Spain

  • Study on the Effectiveness and Safety of OTL-203 for Patients with Hurler Syndrome (MPS-IH) Compared to Standard Treatment with Stem Cell Transplantation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy The Netherlands

  • Study of [177Lu]Lu-NeoB and Capecitabine for Patients with Advanced Breast Cancer Resistant to Hormone Therapy

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy The Netherlands Portugal Spain

  • Study on Maribavir for Treating Cytomegalovirus in Children and Adolescents Post-Transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Spain

  • Study on the Effects of Navepegritide and Lonapegsomatropin in Children with Achondroplasia

    Not recruiting

    2 1 1
    Investigated Drugs:
    Denmark Ireland

  • Study on the Effects of AR1001 (Mirodenafil Dihydrochloride) for Patients with Early Alzheimer’s Disease

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Denmark France Germany Italy The Netherlands +2

  • Study of Farletuzumab Ecteribulin for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Spain

  • Study Comparing Rituximab and Zanubrutinib with Rituximab Alone for Untreated Patients with Splenic Marginal Zone Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Denmark France Italy Norway Spain +1

  • Study Comparing INBRX-101 and Human Alpha1-Proteinase Inhibitor for Adults with Alpha-1 Antitrypsin Deficiency Emphysema

    Not recruiting

    2 1 1
    Investigated Drugs:
    Denmark Ireland Poland Spain Sweden

  • Study on Acalabrutinib for Very Old or Frail Patients with Chronic Lymphocytic Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Germany

powered by